Cannabidiol Market Size, Trend And Industry Report 2027

Cannabidiol Market Outlook:

Cannabidiol (CBD) is one of 113 identified cannabinoids in cannabis plants and accounts for up to 40% of the plant's extract. It is the second most prevalent of the active ingredients of cannabis (marijuana). CBD is commonly used to address anxiety, and for patients who suffer through the misery of insomnia. CBD oil is used in several medical applications such as treatment of anxiety and depression, stress relief, diabetes prevention, mitigation of pain, alleviation of cancer symptoms, and acne reduction.

Impact of Covid-19 on market:

Pharmaceutical and biotech companies along with governments around the globe are working to address the COVID-19 outbreak from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

According to numerous studies, CBD helps decrease seizures, and sometimes it stops them altogether. High cost of CBD products, the presence of stringent regulations, absence of legalization programs in several countries and side effects such as nausea, fatigue, and irritability are the factors the limit the market growth.

Recently the FDA approved the first ever cannabis-derived medicine for these conditions, Epidiolex, which contains CBD. Reducing side effects of the medicines is the main challenge for the manufacturers in the market.

Usage of Cannabidiol in Coffee:

The most effective therapeutic dose of CBD for any particular medical condition and a medicine with lesser or no side effects can be developed, as an add-in-booster to post work out smoothie or morning coffee. Also, launch of these add-in boosters to coffee help reduce the side effects of caffeine, which drives the cannabidiol market growth.

Increase in Awareness about Cannabidiol:

Increase in awareness about the therapeutic benefits and healing properties of Cannabidiol are expected to benefit the market growth. Moreover, this rise in awareness is expected to increase its public acceptance and further driving the cannabidiol market growth. The government continues to invest in research and supports public awareness campaigns to provide facts on cannabis and promote guidelines for lower-risk usage in various countries such as Canada.

Key Benefits of the Report:

This study presents the analytical depiction of the global cannabidiol market along with the current trends and future estimations to determine the imminent investment pockets.
The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global cannabidiol market share.
The current market is quantitatively analyzed to highlight the global cannabidiol market growth scenario.
The report provides a detailed global cannabidiol market analysis based on competitive intensity and how the competition will take shape in the coming years.

Questions answered in the Cannabidiol Market research report:

What are the leading market players active in the Cannabidiol market since few years?
What are the driving factors, challenges, and opportunities in the market?
What are the projections for the future that would help in taking further strategic steps?

Cannabidiol Market Report Highlights

Aspects	Details
By Treatment	CBD Oil Supplements
By Distributions	Retail Pharmacies & Drug Stores e-Commerce Others
By Region	North America (U.S., Canada, Mexico) Europe (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	Pharmahemp d.o.o, Isodiol International Inc, Medical Marijuana Inc, Elixinol, Walgreens Boots Alliance, NULeaf Naturals LLC, Rite Aid, CVS Health, Encoda Inc., Folium Biosciences
Other Players	Cannoid, LLC;